Quest Investment Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Quest Investment Management's PFE Position: Q2 2026 in Review
Quest Investment Management reduced its Pfizer (PFE) stake by 26% in Q2 2026, selling an estimated $210K and leaving 22,370 shares worth $539K. The position accounts for 0.06% of the portfolio, ranked #91.
Quest Investment Management first reported a position in PFE in Q2 2025 and has held it in 5 quarters since. The position peaked at $853K in Q1 2026. 2,834 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Quest Investment Management held 22,370 shares of Pfizer worth $539K as of Q2 2026.
- Quest Investment Management sold 8,025 Pfizer shares in Q2 2026, an estimated $210K.
- Pfizer made up 0.06% of Quest Investment Management's portfolio in Q2 2026, its #91 holding.
- Quest Investment Management first reported a position in Pfizer in Q2 2025 and has held it in 5 quarters since.
- Quest Investment Management's Pfizer position peaked at $853K in Q1 2026.
- 2,834 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Quest Investment Management's 13F filing for Q2 2026, filed 13 Aug 2026.